News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SAN.PA) CEO is Open to Deals of Up to $2.6 Billion This Year, Will Trim Another $170 Million in Annual Costs


1/11/2012 8:29:18 AM

Sanofi, the French drugmaker that bought Genzyme Corp. of the U.S., is planning “bolt-on” acquisitions of up to 2 billion euros ($2.6 billion) this year, Chief Executive Officer Chris Viehbacher said. Viehbacher, who defines his acquisition strategy as a “string of pearls,” will keep on adding “more pearls” going forward, the 51-year-old executive said in an interview in San Francisco today. Paris-based Sanofi will stick to transactions “in the order of 1 billion to 2 billion euros per year,” Viehbacher said. “It’s not a budget. I am pretty happy with the shape of the company. All we want to do is continue to look for opportunities, particularly in emerging markets.”

Read at Bloomberg
Read at Boston Globe


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES